Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Curr Opin Biomed Eng. 2017 Sep;3:56–66. doi: 10.1016/j.cobme.2017.11.001

Figure 3. MRF in prostate cancer.

Figure 3

(A) T2 weighted axial image of a patient with a high-grade prostate cancer (Gleason score 9) shows a large hypointense lesion involving peripheral zone (white thick arrow) while the normal peripheral zone is hyperintense (green thin arrow). (B) Apparent diffusion coefficient (ADC) map shows diffusion restriction (dark on ADC map) in prostate cancer (white thick arrow) while normal peripheral zone shows no diffusion restriction (green thin arrow). (C, D) show MRF-derived quantitative T1 and T2 color maps respectively. The mean T1 and T2 values for prostate cancer were 1533 ± 175 ms and 36.8 ± 6.7 ms respectively while the mean T1 and T2 values for the normal peripheral zone were 2920 ± 80 ms and 261 ± 57 ms respectively.